Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-800-4 | CAS number: 88-12-0
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
n-Vinylpyrrolidone (nVP) has not produced genotoxic, mutagenic, or clastogenic activity in any of the various in vivo and in vitro GLP guideline and reliable non-guideline studies that have been performed.
The the following in vitro studies with nVP produced negative results:
- Ames test with or without activation (S9 mix) in the strains TA1535, TA98 or TA100 (BASF, 1978)
- Ames test with or without activation (S9 mix) in the strains TA 1535, TA 1537, TA 98 and TA 100 (HRC, 1978)
- TK locus tests in L5178Y mouse lymphoma cells with and without metabolic activation (GAF, 1980)
- Cell transformation test without S9 mix (BALB/3T3 mouse cells) (GAF, 1980)
- Unscheduled DNA Synthesis test in rat hepatocytes (GAF, 1980)
- Chromosome Aberration test in human lymphocyte cultures (with and without S9 mix) (BASF, 1987)
The following in vivo studies with nVP also produced negative results:
A mouse micronucleus assay (male/female NMRI mice) following a single oral administration of 150, 300, or 600 mg/kg bw (nominal) doses (BASF, 1993). Under the conditions of the study the test substance did not increase the number of micronuclei and Erythropoiesis determined from the ratio of polychromatic to normochromatic erythrocytes was not inhibited. Thus, there was neither a clastogenic effect nor any impairment of chromosome distribution.
A study of DNA binding in rat liver after i.p. injection of single doses of 150 or 300 mg/kg body weight with liver tissue biopsy after 1 and 5 hours and doses on 5 consecutive days with liver biopsy 1 hour after the last injection (BASF, 1986). In preliminary experiments the test substances appeared to be strongly associated with the rat liver DNA fractions, especially after 5 days of dosing. But upon further purification of the DNA samples, the highly purified DNA showed no association of the test substances or their metabolites. There was evidence of other major binding molecules such as glycogen.
Short description of key information:
Not genotoxic, mutagenic, or clastogenic in vitro or in vivo.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
n-Vinylpyrrolidone (nVP) should not be classified as mutagenic under either the EU DSD classification criteria (Directive 67/548/EEC) or the EU CLP classification criteria (Regulation (EC) 1272/2008) on the basis of negative results in all in vivo and in vitro GLP guideline and reliable non-guideline studies that have been performed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
